Home Applications 217242 Application 217242
Type NDA
Sponsor ARCUTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZORYVE ROFLUMILAST FOAM;TOPICAL 0.3% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217242-001 ZORYVE ROFLUMILAST 0.3% FOAM / TOPICAL RLD, RS 2023-12-15
Orange Book patents# Current patent rows page 1 of 1 · 26 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217242-001 NP 2026-12-15 N217242-001 I-969 2028-05-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 1c564ffb4f44…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217242-001 10940142 2037-06-07 Drug product 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11793796 2037-06-07 Drug product 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11819496 2037-06-07 U-4203 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11819496 2037-06-07 U-3773 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11992480 2037-06-07 U-4203 2024-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11992480 2037-06-07 U-3773 2024-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12005051 2037-06-07 U-4203 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12005051 2037-06-07 U-3773 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12005052 2037-06-07 Drug product 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12011437 2037-06-07 Drug product 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12016848 2037-06-07 Drug product 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12042487 2037-06-07 Drug product 2024-08-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12220409 2037-06-07 Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12257242 2037-06-07 Drug product 2025-04-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12310956 2037-06-07 U-3773 2025-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12310956 2037-06-07 U-4203 2025-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12336983 2037-06-07 Drug product 2025-07-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12390453 2037-06-07 Drug product 2025-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 9884050 2037-06-07 Drug product 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 9907788 2037-06-07 U-4203 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 9907788 2037-06-07 U-3773 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11129818 2037-08-25 U-4203 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11129818 2037-08-25 U-3773 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11707454 2041-12-03 U-3773 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12329751 2041-12-03 U-3773 2025-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12453721 2042-08-19 Drug product 2025-11-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 10940142 2037-06-07 Drug product 2023-12-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 11793796 2037-06-07 Drug product 2023-12-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 11819496 2037-06-07 U-4203 2023-12-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 11819496 2037-06-07 U-3773 2023-12-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 11992480 2037-06-07 U-4203 2024-06-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 11992480 2037-06-07 U-3773 2024-06-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12005051 2037-06-07 U-4203 2024-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12005051 2037-06-07 U-3773 2024-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12005052 2037-06-07 Drug product 2024-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12011437 2037-06-07 Drug product 2024-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12016848 2037-06-07 Drug product 2024-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12042487 2037-06-07 Drug product 2024-08-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12220409 2037-06-07 Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 12257242 2037-06-07 Drug product 2025-04-22 31067a03dcf5…
Observed Orange Book exclusivity history# openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ZORYVE ROFLUMILAST Arcutis Biotherapeutics, Inc. f9e0b4a9-a227-4947-b00c-41fb18d16589 2026-06-22 Warnings, Adverse reactions Exact identifier application applno (NDA): 217242 application number: NDA217242
Documents# Document, Submission type, Date table Document Submission type Date 82436 SUPPL 2025-06-03 82317 SUPPL 2025-05-27 79551 SUPPL 2024-09-06 79548 SUPPL 2024-09-06 78205 ORIG 2024-04-23 77064 ORIG 2023-12-19 76874 ORIG 2023-12-15